ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,323Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 1454

$1.48M Total Retail Price of All Prescriptions

Rank: 24 out of 1454

1,142 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 1,142 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 1,142 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 24,738 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
LISINOPRIL 1,511 1,202 1 4
OMEPRAZOLE 1,437 1,000 2 3
AMLODIPINE BESYLATE 1,436 1,215 3 2
HYDROCODONE-ACETAMINOPHEN 1,074 709 S3 4 7
FUROSEMIDE 1,049 886 5 6
METFORMIN HCL 964 692 6 8
SIMVASTATIN 855 624 7 1
LEVOTHYROXINE SODIUM 771 629 8 5
METOPROLOL TARTRATE 653 507 9 10
GABAPENTIN 611 392 10 16
ATENOLOL 576 441 11 18
HYDROCHLOROTHIAZIDE 549 447 12 9
POTASSIUM CHLORIDE 525 413 13 15
WARFARIN SODIUM 514 436 14 17
METOPROLOL SUCCINATE 506 433 15 13
CITALOPRAM HBR 425 332 16 21
GLIMEPIRIDE 423 318 17 33
SERTRALINE HCL 368 298 18 26
ATORVASTATIN CALCIUM 359 288 19 11
CIPROFLOXACIN HCL 314 241 20 64
ZOLPIDEM TARTRATE 293 203 21 19
CYCLOBENZAPRINE HCL 266 128 R 22 59
NEXIUM 265 202 23 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 260 207 24 27
BENAZEPRIL HCL 255 175 25 57
DONEPEZIL HCL 251 245 26 29
PRAVASTATIN SODIUM 241 203 27 12
ADVAIR DISKUS 236 168 28 47
LOVASTATIN 236 175 28 39
AZITHROMYCIN 236 184 28 42
ISOSORBIDE MONONITRATE ER 235 231 31 46
CLONIDINE HCL 224 155 32 49
ALLOPURINOL 223 147 33 28
PREDNISONE 213 164 34 36
TAMSULOSIN HCL 212 175 35 34
POLYETHYLENE GLYCOL 3350 211 176 36 61
FLUTICASONE PROPIONATE 202 141 37 30
SPIRIVA 195 173 38 52
PANTOPRAZOLE SODIUM 190 131 39 31
DICLOFENAC SODIUM 189 147 40 118
DIOVAN 188 138 41 40
MELOXICAM 184 156 42 37
CLOPIDOGREL 180 136 43 32
TRAMADOL HCL 178 142 44 20
CARVEDILOL 175 130 45 24
TRAZODONE HCL 171 135 46 50
LANTUS 166 112 47 51
ALENDRONATE SODIUM 162 150 48 35
PROAIR HFA 160 72 49 56
NAMENDA 159 154 50 48
LOSARTAN POTASSIUM 156 138 51 14
DILTIAZEM 24HR CD 152 129 52 76
RANITIDINE HCL 140 94 53 43
SYNTHROID 140 124 53 25
AMLODIPINE BESYLATE-BENAZEPRIL 138 104 55 65
DILTIAZEM 24HR ER 138 137 55 120
DIOVAN HCT 128 110 57 75
COUMADIN 126 126 58 119
DILTIAZEM ER 125 109 59 126
ACTOS 124 105 60 90
AMITRIPTYLINE HCL 124 87 R 60 71
RAMIPRIL 123 111 62 66
GEMFIBROZIL 121 71 63 128
LANTUS SOLOSTAR 121 84 63 79
PROPRANOLOL HCL 120 109 65 129
SULFAMETHOXAZOLE-TRIMETHOPRIM 119 81 66 108
CYMBALTA 118 62 67 55
CRESTOR 117 77 68 22
MIRTAZAPINE 116 111 69 53
TRIAMCINOLONE ACETONIDE 109 92 70 142
PLAVIX 108 82 71 45
PROMETHAZINE HCL 106 88 R 72 82
OXYCODONE-ACETAMINOPHEN 106 75 S2 72 60
TRIAMTERENE-HCTZ 106 85 72 44
DIGOXIN 104 93 75 70
GLIPIZIDE XL 103 99 76 85
PAROXETINE HCL 102 79 77 73
QUETIAPINE FUMARATE 102 91 77 91
GLIPIZIDE ER 98 98 79 92
FLUOXETINE HCL 96 50 80 72
VENTOLIN HFA 96 72 80 112
LYRICA 95 52 82 103
INSULIN SYRINGE 95 61 82 97
DOXYCYCLINE HYCLATE 85 77 84 110
MECLIZINE HCL 81 68 85 132
DOXAZOSIN MESYLATE 81 69 85 87
MEGESTROL ACETATE 81 81 R 85 219
GLYBURIDE 78 76 R 88 98
BUPROPION HCL SR 78 44 88 207
AMOXICILLIN 77 55 90 133
EXFORGE 76 52 91 198
CHLORTHALIDONE 74 71 92 109
LIPITOR 74 52 92 74
KLOR-CON M20 72 50 94 54
ALPRAZOLAM 72 64 94 296
DETROL LA 71 56 96 225
VENLAFAXINE HCL ER 71 47 96 105
PHENYTOIN SODIUM EXTENDED 68 31 98 138
METFORMIN HCL ER 68 32 98 41
SPIRONOLACTONE 66 64 100 63
ESCITALOPRAM OXALATE 65 40 101 78
QUINAPRIL HCL 65 59 101 101
COMBIVENT 64 38 103 115
HYDRALAZINE HCL 63 63 104 67
LEVOFLOXACIN 63 51 104 95
LEVEMIR FLEXPEN 62 43 106 171
FEXOFENADINE HCL 62 61 106 342
NOVOLOG 62 46 106 99
EXELON 60 60 109 135
NYSTATIN 57 39 110 184
CEFUROXIME 57 44 110 150
LABETALOL HCL 56 47 112 147
GLYBURIDE-METFORMIN HCL 56 28 R 112 139
FINASTERIDE 55 39 114 94
BUPROPION HCL 53 15 115 352
SYMBICORT 53 31 115 143
ROPINIROLE HCL 53 48 115 96
VERAPAMIL ER 53 49 115 89
NOVOLOG FLEXPEN 52 49 119 157
LEVOXYL 51 51 120 84
VESICARE 50 50 121 199
PIOGLITAZONE HCL 50 42 R 121 235
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.